These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 20060765

  • 1. Clinical and metabolic characteristics of patients with latent autoimmune diabetes in adults (LADA): absence of rapid beta-cell loss in patients with tight metabolic control.
    Chaillous L, Bouhanick B, Kerlan V, Mathieu E, Lecomte P, Ducluzeau PH, Delamaire M, Sonnet E, Maugendre D, Maréchaud R, Rohmer V, Saï P, Charbonnel B.
    Diabetes Metab; 2010 Feb; 36(1):64-70. PubMed ID: 20060765
    [Abstract] [Full Text] [Related]

  • 2. Rosiglitazone combined with insulin preserves islet beta cell function in adult-onset latent autoimmune diabetes (LADA).
    Zhou Z, Li X, Huang G, Peng J, Yang L, Yan X, Wang J.
    Diabetes Metab Res Rev; 2005 Feb; 21(2):203-8. PubMed ID: 15386806
    [Abstract] [Full Text] [Related]

  • 3. A clinically orientated approach increases the efficiency of screening for latent autoimmune diabetes in adults (LADA) in a large clinic-based cohort of patients with diabetes onset over 50 years.
    Monge L, Bruno G, Pinach S, Grassi G, Maghenzani G, Dani F, Pagano G.
    Diabet Med; 2004 May; 21(5):456-9. PubMed ID: 15089790
    [Abstract] [Full Text] [Related]

  • 4. Autoimmune diabetes in adults: lessons from the UKPDS.
    Desai M, Clark A.
    Diabet Med; 2008 Aug; 25 Suppl 2():30-4. PubMed ID: 18717976
    [Abstract] [Full Text] [Related]

  • 5. The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with Type 2 diabetes mellitus.
    Arikan E, Sabuncu T, Ozer EM, Hatemi H.
    J Diabetes Complications; 2005 Aug; 19(5):254-8. PubMed ID: 16112499
    [Abstract] [Full Text] [Related]

  • 6. Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA).
    Lohmann T, Kellner K, Verlohren HJ, Krug J, Steindorf J, Scherbaum WA, Seissler J.
    Diabetologia; 2001 Aug; 44(8):1005-10. PubMed ID: 11484077
    [Abstract] [Full Text] [Related]

  • 7. Glutamic acid decarboxylase 65 autoantibody levels discriminate two subtypes of latent autoimmune diabetes in adults.
    Li X, Yang L, Zhou Z, Huang G, Yan X.
    Chin Med J (Engl); 2003 Nov; 116(11):1728-32. PubMed ID: 14642146
    [Abstract] [Full Text] [Related]

  • 8. [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin].
    Pánczél P, Hosszúfalusi N, Bornemisza B, Horváth L, Jánoskuti L, Füst G, Rajczy K, Vatay A, Prohászka Z, Madácsy L, Luczay A, Blatniczky L, Halmos T, Körner A, Szilvási I, Romics L.
    Orv Hetil; 2001 Nov 18; 142(46):2571-8. PubMed ID: 11770176
    [Abstract] [Full Text] [Related]

  • 9. Clinical characteristics, and time course of pancreatic beta-cell function and glutamic acid decarboxylase antibodies in Thai patients with adult-onset Type 1 diabetes: distinction between patients of rapid- and slow-onset.
    Rattarasarn C, Diosdado MA.
    Horm Metab Res; 1999 May 18; 31(5):311-6. PubMed ID: 10422726
    [Abstract] [Full Text] [Related]

  • 10. [Islet beta cell function in latent autoimmune diabetes in adults with islet cell antibodies].
    Yang L, Zhou ZG, Huang G, Yan X.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun 18; 29(3):309-14. PubMed ID: 16136967
    [Abstract] [Full Text] [Related]

  • 11. Clinical and biochemical characteristics of nonobese type 2 diabetic patients with glutamic acid decarboxylase antibody in Korea.
    Kim CS, Nam JH, Nam JS, Park JS, Kang ES, Ahn CW, Cha BS, Lim SK, Kim KR, Lee HC, Huh KB.
    Metabolism; 2006 Aug 18; 55(8):1107-12. PubMed ID: 16839848
    [Abstract] [Full Text] [Related]

  • 12. Latent autoimmune diabetes in Tunisian adults (LADA): identification of autoimmune markers.
    Amrouche Ch, Jamoussi Kamoun H, Trabelsi N, Blouza Chabchoub S.
    Tunis Med; 2008 Apr 18; 86(4):316-8. PubMed ID: 19476130
    [Abstract] [Full Text] [Related]

  • 13. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group.
    Komulainen J, Knip M, Lounamaa R, Vähäsalo P, Karjalainen J, Sabbah E, Akerblom HK.
    Diabet Med; 1997 Jul 18; 14(7):532-7. PubMed ID: 9223390
    [Abstract] [Full Text] [Related]

  • 14. Anti-CD38 autoantibodies: characterisation in new-onset type I diabetes and latent autoimmune diabetes of the adult (LADA) and comparison with other islet autoantibodies.
    Mallone R, Ortolan E, Pinach S, Volante M, Zanone MM, Bruno G, Baj G, Lohmann T, Cavallo-Perin P, Malavasi F.
    Diabetologia; 2002 Dec 18; 45(12):1667-77. PubMed ID: 12488956
    [Abstract] [Full Text] [Related]

  • 15. Protective effects of 1-alpha-hydroxyvitamin D3 on residual beta-cell function in patients with adult-onset latent autoimmune diabetes (LADA).
    Li X, Liao L, Yan X, Huang G, Lin J, Lei M, Wang X, Zhou Z.
    Diabetes Metab Res Rev; 2009 Jul 18; 25(5):411-6. PubMed ID: 19488999
    [Abstract] [Full Text] [Related]

  • 16. Equivalent insulin resistance in latent autoimmune diabetes in adults (LADA) and type 2 diabetic patients.
    Chiu HK, Tsai EC, Juneja R, Stoever J, Brooks-Worrell B, Goel A, Palmer JP.
    Diabetes Res Clin Pract; 2007 Aug 18; 77(2):237-44. PubMed ID: 17234296
    [Abstract] [Full Text] [Related]

  • 17. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.
    Keymeulen B, Vandemeulebroucke E, Ziegler AG, Mathieu C, Kaufman L, Hale G, Gorus F, Goldman M, Walter M, Candon S, Schandene L, Crenier L, De Block C, Seigneurin JM, De Pauw P, Pierard D, Weets I, Rebello P, Bird P, Berrie E, Frewin M, Waldmann H, Bach JF, Pipeleers D, Chatenoud L.
    N Engl J Med; 2005 Jun 23; 352(25):2598-608. PubMed ID: 15972866
    [Abstract] [Full Text] [Related]

  • 18. [Association of autoantibody and cytokines with latent autoimmune diabetes in adults].
    He FP.
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec 23; 23(12):1323-5. PubMed ID: 14678903
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of LADA and frequency of GAD antibodies in diabetic patients with end-stage renal disease and dialysis treatment in Austria.
    Biesenbach G, Auinger M, Clodi M, Prischl F, Kramar R, Diabetic Nephropathy Study Group of the Austrian Society of Nephrology.
    Nephrol Dial Transplant; 2005 Mar 23; 20(3):559-65. PubMed ID: 15671073
    [Abstract] [Full Text] [Related]

  • 20. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.
    Lindholm E, Hallengren B, Agardh CD.
    Diabetes Metab Res Rev; 2004 Mar 23; 20(2):158-64. PubMed ID: 15037992
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.